Publications by authors named "L Yel"

Claim this Profile
E
Efficacy, Safety, Tolerability, and Serum IgG Trough Levels of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% in US Pediatric Patients with Primary Immunodeficiency Diseases.
Niraj C Patel, Jolan E Walter, Richard L Wasserman, Arye Rubinstein, Suthida Kankirawatana, Leman Yel

J Clin Immunol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose, exposure, and treatment regimen of intravenous immunoglobulin G in multifocal motor neuropathy.
Zhaoyang Li, Stefan Roepcke, Ryan Franke, Leman Yel

Front Neurol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
fSCIG 10% in pediatric primary immunodeficiency diseases: a European post-authorization safety study.
Peter Čižnár, Marion Roderick, Helen Schneiderova, Miloš Jeseňák, Gergely Kriván, Leman Yel

Allergy Asthma Clin Immunol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-exposure-efficacy response of intravenous immunoglobulin G 10% in multifocal motor neuropathy.
Zhaoyang Li, Stefan Roepcke, Ryan Franke, Leman Yel

Ann Clin Transl Neurol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Safety of Facilitated Subcutaneous Immunoglobulin 10% Treatment in US Clinical Practice in Patients with Primary Immunodeficiency Diseases: Results from a Post-Authorization Safety Study.
Arye Rubinstein, Mohsen Mabudian, Donald McNeil, Niraj C Patel, Richard L Wasserman, Leman Yel

J Clin Immunol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis